Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02275871 · ClinicalTrials.gov registry record · NA
Comparison of Contrast-enhanced Spectral Mammography (CESM) to MRI in Screening High Risk Women for Breast Cancer
A NA study, sponsored by Beth Israel Deaconess Medical Center.
- Terminated
- Registry status
- NA
- Development phase
- 44
- Enrollment target
NCT02275871 is a NA study that was terminated before completion, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 44 participants.
The verdict
NCT02275871, a NA study, was terminated before completion, sponsored by Beth Israel Deaconess Medical Center.
- TERMINATED
- Registry status
- NA
- Development phase
- 44 participants
- Enrollment target
Study Summary
This research study is comparing Dual-Energy Contrast-Enhanced Spectral Mammography (CESM) to MRI as a screening tool for breast cancer.
Interventions
- OTHER MRI
- OTHER CESM
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2014-11 |
| Est. Completion | 2020-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02275871
The ClinicalTrials.gov registry entry for NCT02275871 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 44 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Beth Israel Deaconess Medical Center, which has 488 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which MRI is the first listed.
NCT02275871 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02275871 about?
NCT02275871 is a clinical study titled "Comparison of Contrast-enhanced Spectral Mammography (CESM) to MRI in Screening High Risk Women for Breast Cancer". This research study is comparing Dual-Energy Contrast-Enhanced Spectral Mammography (CESM) to MRI as a screening tool for breast cancer.
What is the current status of trial NCT02275871?
This trial is currently terminated. It is a NA study. The enrollment target is 44 participants. The study started on 2014-11. Estimated completion is 2020-01.
What interventions are being tested in trial NCT02275871?
The interventions under investigation include: MRI (OTHER), CESM (OTHER).
Who is sponsoring clinical trial NCT02275871?
This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.